Physiological bone formation is essential for the normal functioning of the skeleton whilst pathological vascular calcification has many negative effects. This project is focused on understanding the similarities and, more importantly, the differences between these processes. This information is required to develop treatments for vascular calcification that do not cause bone loss.

Challenge       

Physiological bone formation is essential for the normal functioning of the skeleton. In contrast, calcification within soft tissues has numerous negative physiological effects. Consequently, there are multiple mechanisms in place to prevent soft tissues from calcifying. When these regulatory processes fail unwanted mineral deposition can occur, a good example being vascular calcification. Vascular calcification is the formation of bone-like deposits within blood vessels and heart valves and is a significant risk factor for future adverse cardiovascular events such as heart attack and stroke.

Solution      

Despite recent advances in understanding about how vascular calcification develops, there are still no effective treatments to prevent or treat this condition. Earlier research has shown that there are some outward similarities between bone formation and vascular calcification. However, targeting processes or pathways common to both processes risks off target adverse skeletal effects.

Impact      

This project is focused on understanding the similarities and, more importantly, the differences between bone formation and vascular calcification. This information is required to develop treatments for vascular calcification that do not cause bone loss. In parallel, we are also working to develop novel protocols to study vascular calcification that do not use any animals or their derived products.

This research is being performed in our Camden campus, using the combined skills and expertise of vascular and skeletal biologists. This collaboration ensures that the very best, cutting edge approaches are combined with extensive knowledge of bone and vascular physiology to improve understanding in this area. Ultimately it hopes to identify novel pathways that can be targeted therapeutically to treat this serious, life threatening condition.

Partners      

British Heart Foundation

The Humane Research Trust

Publications     

Title Publication Year
Opdebeeck B, Vandenbranden A, Adriaensen S, Orriss IR, Patel JJ, Geryl H, Zwijsen K, D’Haese PC, Verhulst A (2024). β,γ-Methylene-ATP and its metabolite medronic acid affect both arterial media calcification and bone mineralization in non-CKD and CKD rats. JBMR 2024
Bourne LE, Davies, BK, Millan JL, Arnett TR, Wheeler-Jones CPD, Keen JAC, Roberts SJ, Orriss IR (2023). Evidence that pyrophosphate acts as an extracellular signalling molecule to exert direct functional effects in primary cultures of osteoblasts and osteoclasts. Bone 2023
Opdebeeck B, Huysmans I, Van den Branden A, Orriss IR, Verhulst A (2022). Deletion of the P2Y2 receptor aggravates internal elastic lamina calcification in chronic kidney disease through upregulation of alkaline phosphatase and lipocalin-2.  FASEBJ 2023
Bourne LE, Patel JJ, Davies BK, Neven E, Verhulst A, D’Haese PC, Wheeler-Jones CPD, Orriss IR. (2022). N-acetylcysteine (NAC) differentially affects arterial medial calcification and bone formation: the role of L-cysteine and hydrogen sulphide. J Cell Physiol 2022
Bourne LE, Wheeler-Jones CPD, Orriss IR (2021). Regulation of mineralisation in bone and vascular tissue: a comparative review. J Endocrinol 2021
Patel JJ, Bourne LE, Millan JL, Arnett TR, MacRae VE, Wheeler-Jones CP, Orriss IR (2019). Inhibition of vascular smooth muscle cell calcification by ATP-analogues.  Purinergic Signal 2019
Patel JJ, Bourne LE, Davies BK, Arnett TR, MacRae VE, Wheeler-Jones CP, Orriss IR (2019). Differing calcification processes in cultured vascular smooth muscle cells and osteoblasts. Exp Cell Res 2019
Patel JJ, Zhu D, Opdebeeck B, D’Haese P, Millan JL, Bourne LE, Wheeler-Jones CPD, Arnett TR, MacRae V, Orriss IR (2018). Inhibition of arterial medial calcification and bone mineralisation by extracellular nucleotides: the same functional effect mediated by different cellular mechanisms. J Cell Physiol 2018

 

Top of page